| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: group of inventions relates to biotechnology. The strain Bifidobacterium lactis CNCM I-3446 is applicable in preparing a probiotic composition for stimulating development of initial bifidogenic intestinal microbiota in the children delivered by caesarean section. The strain may be used in preparing the probiotic composition for reducing a risk of further development of allergy, as well as for preventing or treating diarrhoea in these children.EFFECT: group of inventions provides stimulating the intestinal colonisation in the children delivered by caesarean section both with the above strain, and with the other species.78 cl, 6 dwg, 4 tbl, 2 ex |
